A Rare Case of Autoimmune Metaplastic Atrophic Gastritis

Shawn Philip^1, , Luz Sullivan² and Nour Parsa³

¹Albany Medical Center, Department of Internal Medicine, Albany, NY. USA

²Albany Medical Center, Department of Pathology, Albany, NY. USA

³Albany Medical Center, Department of Gastroenterology, Albany, NY. USA

Cite this paper

Shawn Philip, Luz Sullivan and Nour Parsa. A Rare Case of Autoimmune Metaplastic Atrophic Gastritis. American Journal of Medical Case Reports. 2021; 9(10):516-518. doi: 10.12691/AJMCR-9-10-10

Abstract

Autoimmune metaplastic atrophic gastritis is an important pathological finding associated with neoplasia and pernicious anemia. Defined guidelines on surveillance endoscopy for this diagnosis are lacking. We present a rare case of a patient with a known history of pernicious anemia that presented with blood-tinged sputum. The patient underwent endoscopic evaluation with random gastric biopsies that showed a two-month progression from diffuse inflammation to intestinal metaplasia in the background of autoimmune metaplastic atrophic gastritis (AMAG) on surveillance endoscopy. AMAG is an important finding that deserves close endoscopic surveillance as complications can include autoimmune conditions, pernicious anemia,gastric carcinoid, and gastric adenocarcinoma.

Keywords

gastritis, pernicious anemia, autoimmune metaplastic atrophic gastritis

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010; 31(9): 1042-1050.
[2]	Park JY, Lam-Himlin D, Vemulapalli R. Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc. 2013; 77(2): 284-292.
[3]	Pittman ME, Voltaggio L, Bhaijee F, Robertson SA, Montgomery EA. Autoimmune metaplastic atrophic gastritis. Am J Surg Pathol. 2015; 39(12): 1611-1620.
[4]	De Block CEM, De Leeuw IH, Van Gaal LF. High Prevalence of Manifestations of Gastric Autoimmunity in Parietal Cell Antibody- Positive Type 1 (Insulin-Dependent) Diabetic Patients 1. J Clin Endocrinol Metab. 1999; 84(11): 4062-4067.
[5]	Lahner E, Centanni M, Agnello G, et al. Occurrence and Risk Factors for Autoimmune Thyroid Disease in Patients with Atrophic Body Gastritis. Am J Med. 2008; 121(2): 136-141.
[6]	Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009; 104(8): 2071-2079.
[7]	Hung OY, Maithel SK, Willingham FF, Farris AB, Kauh JS. Hypergastrinemia, type 1 gastric carcinoid tumors: Diagnosis and management. J Clin Oncol. 2011; 29(25): e713-e715.
[8]	Karlsson FA, Burman P, Loof L, Mardh S. Major parietal cell antigen in autoimmune gastritis with pernicious anemia is the acid-producing H+,K+-adenosine triphosphate of the stomach. J Clin Invest. 1988; 81(2): 475-479.
[9]	Vasconcelos OM, Poehm EH, McCarter RJ, Campbell WW, Quezado ZMN. Potential outcome factors in subacute combined degeneration: Review of observational studies. J Gen Intern Med. 2006; 21(10): 1063-1068.
[10]	Metzler D, Miller WH, Stephen Edwards C. Psychiatric Manifestation of Vitamin B-12 Deficiency: An Update. Jefferson J Psychiatry. Published online 1991.
[11]	Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR. Autoimmune atrophic gastritis: Current perspectives. Clin Exp Gastroenterol. 2017; 10: 19-27.
[12]	Nehme, Fredy; Green, Michael; Salyers, William; Tofteland N. Case Series of Autoimmune Metaplastic Atrophic Gastritis and Association with Neuroendocrine Tumors of the Stomach. Am J Gastroenterol. 2016; 111(p): S1149.
[13]	Moore AR, Boyce M, Steele IA, Campbell F, Varro A, Pritchard DM. Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis. PLoS One. 2013; 8(10).
[14]	Massironi S, Zilli A, Fanetti I, Ciafardini C, Conte D, Peracchi M. Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. Dig Liver Dis. 2015; 47(11): 978-983.
[15]	Kapadia CR. Gastric atrophy, metaplasia, and dysplasia: A clinical perspective. In: Journal of Clinical Gastroenterology. Vol 36. J Clin Gastroenterol; 2003.
[16]	Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: Gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013; 37(4): 375-382.
[17]	Merola E, Sbrozzi-Vanni A, Panzuto F, et al. Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate. Neuroendocrinology. 2012; 95(3): 207-213.